Page 6 - Diabetes

Study finds why people with diabetes develop severe Covid-19

A recent study by a team of international clinical researchers reveals the mechanism behind cytokine storm during coronavirus infection.

Startup Sugar.fit, which aims to reverse diabetes, to raise $10 million

Health and fitness firm Cure.fit and two others to invest the funds in a deal likely to by September

Wockhardt's growth tonic: Covid vaccines add a third prong to biz strategy

In India, Wockhardt aims to make 2 billion doses of Covid-19 vaccines within the next one or two years but has not disclosed the identity of the tie-ups

Ethnic diversity helps identify more diabetes-related genomic regions

By including multi-ethnic participants, a large-scale genetic study by the University of Exeter has identified more regions of the genome linked to type-2 diabetes-related traits

Two pandemics clash as doctors find that coronavirus spurs diabetes

When Ziyad Al-Aly's research team told him how often diabetes appeared to strike Covid-19 survivors, he thought the data must be wrong, so he asked his five colleagues to crunch the numbers again.

Big Tech uses AI to arrest blindness among India's burgeoning diabetics

Diabetic retinopathy is a leading cause of blindness and vision loss in adults and tech giants such as Intel and Google are building AI-based innovations to address such problems

Covid vaccination voluntary, those already infected can also get the jab

A detailed FAQ released by health ministry has also addressed issues on suitability in co-morbid cases, delivery procedure among other things

AstraZeneca aims to impact 10 mn diabetics by 2023, starts awareness drive

India will have 115 mn diabetics by 2030. Forty-four per cent of patients hospitalised for heart failure have type-2 diabetes

Diabetic eye disease associated with five-fold risk of severe coronavirus

People with diabetes and eye disease have a five-fold increased risk of requiring intubation when hospitalised with Covid-19, suggest the findings of a new study

Ahead of World Diabetes Day, experts call for action to address epidemic

Ahead of World Diabetes Day, a new report has called for action to close the gap in diabetes prevention and care

Sun Pharma arm recalls one lot of diabetes drug Riomet ER oral in US

Sun Pharma has said it is voluntarily recalling one lot of Riomet ER oral suspension in the US market, due to the presence of a probable human carcinogen above the acceptable daily intake limit.

Lupin recalls diabetes treatment drug Metformin Hydrochloride in US

Drug major Lupin Ltd on Wednesday said it is voluntarily recalling its diabetes treatment drug Metformin Hydrochloride extended-release tablets in the US market

Cipla, Boehringer Ingelheim to co-sell 3 oral anti-diabetic drugs in India

Pharma major Cipla and drug firm Boehringer Ingelheim India on Monday announced partnership to co-market three new oral anti-diabetic drugs in the country. The companies have entered into a partnership for co-marketing three new oral anti-diabetics drugs --- Oboravo (Empagliflozin),Oboravo Met (Empagliflozin+Metformin) and Tiptengio (Empagliflozin+Linagliptin) in India, Cipla and Boehringer Ingelheim India Pvt Ltd said in a statement. As per the International Diabetes Federation, India is home to 7.7 crore diabetic adults aged between 20-79 years, ranking second behind China, and is poised to reach 13.42 crore patients by 2045, it added. "Diabetes continues to be a focus area for Cipla and with a strategic partnership with Boehringer Ingelheim coupled with our strong brand building, patient access and reach capabilities, we will be at the forefront of providing holistic diabetes care," Cipla India Business Executive VP & CEO Nikhil Chopra said. In a similar vein, Boehringer ...

Covid-19 and diabetes: Different risks for people with type 1 and type 2

It is still unclear whether people with diabetes are more likely to catch the virus

Shramik trains: Rlys appeal to people with comorbidities to avoid travel

At least nine passengers were reported dead on May 27 over a span of 48 hours on board the migrant trains, with the railways stating that all of them had health conditions.

Why nutrition labels that skip ingredients like sugar make business sense

Veer Arjun Singh on why shorter, sharper nutrition labels - the kind that skip a few ingredients such as sugar by many other names - are starting to make business sense

Yoga to acupuncture: Alternative therapies to prevent diabetic neuropathy

The best defense against progressive damage from diabetic neuropathy is to manage the disease itself

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Pharmaceutical firms seek nod to produce raw material locally

How to manage diabetic neuropathy using therapies from natural systems

In severe cases, it can lead to potentially serious complications such as gangrenous wounds that necessitate the amputation of a toe, foot or leg

New AI tool can predict gestational diabetes risk before pregnancy: Report

Researchers have developed an algorithm which can predict the risk of gestational diabetes even before pregnancy, an advance that may lead to lifestyle interventions for reducing high blood sugar which affects nearly one in six pregnant women. The study, published in the journal Nature Medicine, analysed data on nearly 6,00,000 pregnancies available from Israel's largest health organisation, Clalit Health Services. "Our ultimate goal has been to help the health system take measures so as to prevent diabetes from occurring in pregnancy," said study senior author Eran Segal from the Weizmann Institute of Science in Israel. According to the researchers, gestational diabetes is characterised by high blood sugar levels which occur during pregnancy in women with no history of diabetes. They said the condition occurs in three to nine per cent of all pregnancies, and poses a risk to both the mother and her baby. Generally, the scientists said, gestational diabetes is diagnosed between the